Skip to main content
logo
Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
28.32
-0.16 (-0.56%)
Sep 29, 2026, 12:07 PM EDT - Market open

Neurogene Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.93---
Revenue Growth
------
Gross Profit
-88.38-74.89-59.9-44.39-47.51-42.26
Operating Income
-121.23-103.21-82.51-55.58-56.52-50.53
Net Income
-111.11-90.35-75.1413.65-55.19-50.52
Earnings Per Share
-5.04-4.24-4.282.93-139.88-12.47
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
225.39269.01312.41197.1682.0270.54
Total Debt
8.359.8912.4314.974.695.21
Net Cash (Debt)
217.05259.12299.98182.1977.3365.34
Net Cash Growth
-17.65%-13.62%64.65%135.59%18.36%-
Net Cash Per Share
9.8512.1517.0839.12196.0116.13

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-86.82-77.17-70.6-51.42-52.82-46.4
Capital Expenditures
-0.89-1.18-0.81-0.32-2.23-18.37
Free Cash Flow
-87.71-78.36-71.41-51.74-55.05-64.77
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
---8920.43%---
Pretax Margin
---8123.68%---
Profit Margin
---8123.68%---
FCF Margin
---7720.11%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---18.20--
PS Ratio
--367.11---